Current Report Filing (8-k)
May 08 2020 - 06:06AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported): May 7,
2020
America Great Health
(Exact name of registrant as specified in charter)
WYOMING
(State or other jurisdiction of incorporation)
0-27873
|
|
98-0178621
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
1609 W Valley Blvd., #338,
Alhambra, CA
|
|
91803
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant's telephone number, including area
code: (626) 576-1299
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
☐ Written communications pursuant to
Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
☐ Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Section 4. Matters Related to Accountants and
Financial Statements
Item 4.01. Changes in Registrant’s Certifying
Accountant
|
(a)
|
Resignation of Current Accountants
|
In April, 2019, America Great Health (the “Company”) was notified
of the resignation of its independent registered public accounting
firm, MJF & Associates, LLP (“MJF”), effective that date. The
Company’s Board of Directors accepted the resignation of MJF upon
receipt of the notification and has commenced a search for a new
independent public accounting firm.
No report of MJF on the financial statements of the Company’s
fiscal years ended June 30, 2018 contained an adverse opinion or a
disclaimer of opinion or was qualified or modified as to
uncertainty, audit scope, or accounting principles. MJF at the time
of resignation had not yet released a report or opinion regarding
the Company’s financial statements for the fiscal year ended June
30, 2019. During the time of their engagement and up through their
resignation on, there were no disagreements with MJF on any matters
of accounting principles or practices, financial statement
disclosure or auditing scope and procedures which, if not resolved
to the satisfaction of MJF, would have caused MJF to make reference
to the matter in their report. There were no reportable events (as
that term is described in Item 304(a)(1)(v) of Regulation S-K)
during the fiscal year ended June 30, 2018.
|
(b)
|
Engagement of New Accountants
|
On April 30, 2020, the Company engaged TAAD LLP (“TAAD”) as our
independent registered public accounting firm to audit the
Company’s consolidated financial statements for its fiscal year
ended June 30, 2019.
During the Company’s most recent fiscal years and through the date
of this report, (a) the Company has not engaged TAAD as either the
principal accountant to audit the Company’s financial statements,
or as an independent accountant to audit a significant subsidiary
of the Company and on whom the principal accountant is expected to
express reliance in its report; and (b) the Company or someone on
its behalf did not consult TAAD with respect to (i) either: the
application of accounting principles to a specified transaction,
either completed or proposed; or the type of audit opinion that
might be rendered on the Company’s financial statements, or (ii)
any other matter that was either the subject of a disagreement or a
reportable event as set forth in Items 304(a)(1)(iv) and (v) of
Regulation S-K.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
|
AMERICA GREAT HEALTH
|
|
|
|
|
|
|
|
|
Dated: May 7, 2020
|
|
By:
|
/s/ Mike Q. Wang
|
|
|
|
President
|
America Great Health (PK) (USOTC:AAGH)
Historical Stock Chart
From Dec 2020 to Jan 2021
America Great Health (PK) (USOTC:AAGH)
Historical Stock Chart
From Jan 2020 to Jan 2021